The lack of information on p53 mutation status in our study is a limitation; however, most p53-mutated endometrioid carcinomas are grade 3 tumors, which have a worse prognosis than lower grade carcinomas. The gene discussed is TP53; the disease is endometrioid adenocarcinoma.